Clinician-Guided Care
Every treatment plan is developed and monitored by licensed medical professionals to ensure safety, accuracy, and proper dosing.
+
+
.7★
Microdosing means using a much smaller amount of a GLP-1 medication than traditional protocols. The goal is to support appetite control and metabolic balance gently, rather than pushing for aggressive weight loss or rapid changes.
Microdosing takes a slower, lighter approach, focusing on consistency, tolerability, and day-to-day support instead of maximum results.
Microdosing is often chosen by people who:
Want help with appetite control, not extreme weight loss
Prefer a gentler approach with fewer side effects
Are focused on metabolic health or long-term wellness
Want something that fits more easily into daily life
A licensed provider ultimately determines if it’s appropriate.
Many people do.
Even at lower doses, some people notice:
Reduced hunger or fewer cravings
Feeling satisfied with smaller portions
More stable energy throughout the day
The effects tend to be subtle and gradual, not dramatic.
For many people, yes.
Because the dose is lower, side effects like nausea or digestive discomfort are often milder or easier to tolerate, especially when starting.
That said, side effects are still possible and vary by person.
Most people notice changes within a few weeks, not days.
Microdosing is designed for steady progress, so results tend to build gradually over time rather than happening all at once.
Microdosing is not designed for rapid or dramatic weight loss.
While some people do lose weight, the primary focus is appetite awareness, metabolic support, and consistency rather than hitting a specific number on the scale.
Microdosing still requires a prescription and medical oversight.
Even at low doses, GLP-1 medications affect digestion and metabolism, which is why a licensed provider reviews your health history before approving treatment.
Yes, our microdosing program uses compounded medications, which are prepared by licensed pharmacies.
Compounded medications are not FDA-approved, but they are commonly used when customized dosing or formulations are needed.
Your provider determines whether a compounded option is appropriate.
Microdosing isn’t an all-or-nothing decision. If you’re not noticing meaningful benefits, your provider can reassess your goals and, if appropriate, discuss transitioning into our full GLP-1 program or other options that may be a better fit.
Important Medication Info:
FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or associated with these companies or their products.
Invigor Medical does not supply FDA-approved branded medications. Instead, compounded alternatives may be prescribed when clinically appropriate and legally permissible. These medications are prepared by licensed 503A pharmacies in accordance with the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. They may be prescribed when commercially available products are unsuitable for an individual’s medical needs, but have not been evaluated by the FDA to confirm safety or efficacy for any specific use.
Important Medication Info:
FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™. This website is not affiliated with, endorsed by, or associated with these companies or their products.
Invigor Medical does not supply FDA-approved branded medications. Instead, compounded alternatives may be prescribed when clinically appropriate and legally permissible. These medications are prepared by licensed 503A pharmacies in accordance with the Federal Food, Drug, and Cosmetic Act.
Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. They may be prescribed when commercially available products are unsuitable for an individual’s medical needs, but have not been evaluated by the FDA to confirm safety or efficacy for any specific use.
Important Safety Information for GLP-1 Treatments
Compounded medications are legally prescribed under federal law but are not FDA-approved and have not undergone FDA review for safety, effectiveness, or manufacturing quality. The GLP-1 treatment available through Invigor Medical is prescribed based on an individualized medical evaluation by a licensed clinician.
WARNING: Risk of Thyroid C-Cell Tumors
In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is not known whether these effects occur in humans. Inform your healthcare provider if you experience neck swelling, hoarseness, difficulty swallowing, or shortness of breath. GLP-1 treatments should not be used by individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use GLP-1 treatments if:
Warnings and Precautions:
Pregnancy and Reproductive Health:
GLP-1 medications may cause harm to a fetus and should not be used during pregnancy or when planning to become pregnant. Discontinue at least two months before a planned pregnancy.
Common Side Effects:
Nausea, vomiting, diarrhea, constipation, abdominal discomfort, fatigue, and headache are the most commonly reported side effects.
Drug Interactions:
GLP-1 treatments may slow gastric emptying and affect the absorption of oral medications. Consult your healthcare provider for guidance on medication timing and adjustments.